Dolby Laboratories
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $364,523 | $315,574 | $290,562 | $298,370 |
| Gross Profit | 325,746 | 283,514 | 255,010 | 256,855 |
| EBITDA | 81,955 | 64,851 | ||
| EBIT | 57,698 | 40,547 | ||
| Net Income | 97,830 | 66,981 | 9,186 | 16,399 |
| Net Change In Cash | 364,523 | 315,574 | 290,562 | 298,370 |
| Cost of Revenue | 106,335 | |||
| Free Cash Flow | 172,493 | 2,310 | 76,830 | 113,716 |
| Cash | 709,535 | 656,816 | 745,364 | 765,079 |
| Basic Shares | 95,823 | 95,851 | 97,678 | 97,459 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
| Revenue | $1,009,182 | $1,253,793 | $1,281,256 | $1,161,792 |
| Gross Profit | 892,168 | 1,112,433 | 1,151,231 | 1,015,294 |
| EBITDA | 219,247 | 329,905 | 464,117 | 332,600 |
| EBIT | 219,247 | 206,605 | 344,390 | 218,742 |
| Net Income | 191,470 | 184,087 | 310,227 | 231,363 |
| Net Change In Cash | 1,009,182 | 1,253,793 | 1,281,256 | 1,161,792 |
| Cost of Revenue | -587,917 | 153,053 | 274,386 | |
| Free Cash Flow | 259,912 | 259,120 | 393,299 | 274,862 |
| Cash | 745,364 | 620,127 | 1,225,380 | 1,071,876 |
| Basic Shares | 97,588 | 101,983 | 104,622 | 102,944 |
Earnings Calls
| Quarter | EPS |
|---|---|
| 2024-03-31 | $1.27 |
| 2023-12-31 | $1.01 |
| 2023-09-30 | $0.65 |
| 2023-06-30 | $0.55 |
